<?xml version='1.0' encoding='utf-8'?>
<document id="20175821"><sentence text="Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient."><entity charOffset="11-23" id="DDI-PubMed.20175821.s1.e0" text="voriconazole" /><entity charOffset="27-37" id="DDI-PubMed.20175821.s1.e1" text="tacrolimus" /><pair ddi="false" e1="DDI-PubMed.20175821.s1.e0" e2="DDI-PubMed.20175821.s1.e0" /><pair ddi="false" e1="DDI-PubMed.20175821.s1.e0" e2="DDI-PubMed.20175821.s1.e1" /></sentence><sentence text="Infection occurs frequently in the organ transplant recipients during the post-transplant period because of immunosuppression" /><sentence text=" Therefore, prophylactic antimicrobial agents are often used" /><sentence text=" The azole antifungals, widely prescribed prophylactically, are known to have many drug-drug interactions"><entity charOffset="5-10" id="DDI-PubMed.20175821.s4.e0" text="azole" /></sentence><sentence text=" This report presents a case of drug-drug interaction between voriconazole and tacrolimus in a kidney transplant recipient"><entity charOffset="62-74" id="DDI-PubMed.20175821.s5.e0" text="voriconazole" /><entity charOffset="79-89" id="DDI-PubMed.20175821.s5.e1" text="tacrolimus" /><entity charOffset="69-78" id="DDI-PubMed.20175821.s5.e2" text="azole" /><pair ddi="false" e1="DDI-PubMed.20175821.s5.e0" e2="DDI-PubMed.20175821.s5.e0" /><pair ddi="false" e1="DDI-PubMed.20175821.s5.e0" e2="DDI-PubMed.20175821.s5.e2" /><pair ddi="false" e1="DDI-PubMed.20175821.s5.e0" e2="DDI-PubMed.20175821.s5.e1" /><pair ddi="false" e1="DDI-PubMed.20175821.s5.e2" e2="DDI-PubMed.20175821.s5.e2" /><pair ddi="false" e1="DDI-PubMed.20175821.s5.e2" e2="DDI-PubMed.20175821.s5.e1" /></sentence><sentence text=" Voriconazole treatment led to a dramatic increase in tacrolimus concentration that required its discontinuation in spite of the manufacturer's guidelines that recommend a reduction of tacrolimus dosage by one-third"><entity charOffset="1-13" id="DDI-PubMed.20175821.s6.e0" text="Voriconazole" /><entity charOffset="185-195" id="DDI-PubMed.20175821.s6.e1" text="tacrolimus" /><entity charOffset="8-17" id="DDI-PubMed.20175821.s6.e2" text="azole" /><pair ddi="false" e1="DDI-PubMed.20175821.s6.e0" e2="DDI-PubMed.20175821.s6.e0" /><pair ddi="false" e1="DDI-PubMed.20175821.s6.e0" e2="DDI-PubMed.20175821.s6.e2" /><pair ddi="false" e1="DDI-PubMed.20175821.s6.e0" e2="DDI-PubMed.20175821.s6.e1" /><pair ddi="false" e1="DDI-PubMed.20175821.s6.e2" e2="DDI-PubMed.20175821.s6.e2" /><pair ddi="false" e1="DDI-PubMed.20175821.s6.e2" e2="DDI-PubMed.20175821.s6.e1" /></sentence><sentence text=" The present drug-drug interaction can be attributed to a strong inhibitory effect on cytochrome P450-3A4 activity by voriconazole"><entity charOffset="118-130" id="DDI-PubMed.20175821.s7.e0" text="voriconazole" /><entity charOffset="125-136" id="DDI-PubMed.20175821.s7.e1" text="azole" /><pair ddi="false" e1="DDI-PubMed.20175821.s7.e0" e2="DDI-PubMed.20175821.s7.e0" /><pair ddi="false" e1="DDI-PubMed.20175821.s7.e0" e2="DDI-PubMed.20175821.s7.e1" /></sentence><sentence text=" When voriconazole and tacrolimus are coadministered, close monitoring of tacrolimus blood levels is recommended as the rule-of-thumb reduction of tacrolimus dose by one-third may not be satisfactory"><entity charOffset="6-18" id="DDI-PubMed.20175821.s8.e0" text="voriconazole" /><entity charOffset="23-33" id="DDI-PubMed.20175821.s8.e1" text="tacrolimus" /><entity charOffset="74-84" id="DDI-PubMed.20175821.s8.e2" text="tacrolimus" /><entity charOffset="147-157" id="DDI-PubMed.20175821.s8.e3" text="tacrolimus" /><entity charOffset="13-22" id="DDI-PubMed.20175821.s8.e4" text="azole" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e0" e2="DDI-PubMed.20175821.s8.e0" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e0" e2="DDI-PubMed.20175821.s8.e4" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e0" e2="DDI-PubMed.20175821.s8.e1" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e0" e2="DDI-PubMed.20175821.s8.e2" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e0" e2="DDI-PubMed.20175821.s8.e3" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e4" e2="DDI-PubMed.20175821.s8.e4" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e4" e2="DDI-PubMed.20175821.s8.e1" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e4" e2="DDI-PubMed.20175821.s8.e2" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e4" e2="DDI-PubMed.20175821.s8.e3" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e1" e2="DDI-PubMed.20175821.s8.e1" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e1" e2="DDI-PubMed.20175821.s8.e2" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e1" e2="DDI-PubMed.20175821.s8.e3" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e2" e2="DDI-PubMed.20175821.s8.e2" /><pair ddi="false" e1="DDI-PubMed.20175821.s8.e2" e2="DDI-PubMed.20175821.s8.e3" /></sentence><sentence text="" /></document>